Palisade Bio: Funding, Investors & Team (Oct 2026)
Palisade Bio is a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need. Seneca is in the process of finding and acquiring new assets, promising sciences, and technologies that will provide meaningful therapies for patients.
Palisade Bio has raised $2.0M across 1 funding round on record, the most recent a Post-IPO Equity of $2.0M announced in May 2022.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Palisade Bio Company Profile and Key Stats
Latest funding round on record: May 2022.
Palisade Bio Funding Rounds
Palisade Bio Founders and Leadership Team
No contact details are on record for this team yet.
Palisade Bio Funding Compared to Other Biotechnology Startups
Palisade Bio's latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Palisade Bio in Biotechnology and Germantown
Companies Similar to Palisade Bio
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Palisade Bio Funding FAQs
What does Palisade Bio do?
Palisade Bio is a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need. Seneca is in the process of finding and acquiring new assets, promising sciences, and technologies that will provide meaningful therapies for patients.
How much funding has Palisade Bio raised?
Palisade Bio has raised $2.0M across 1 round on record. The most recent is a Post-IPO Equity of $2.0M announced in May 2022.
When did Palisade Bio last raise funding?
Palisade Bio's most recent funding round on record is a Post-IPO Equity of $2.0M, announced in May 2022.
Who founded Palisade Bio?
FundedIQ lists John Rodenrys (Founder) at Palisade Bio.
Where is Palisade Bio headquartered?
Palisade Bio is based in Germantown, Maryland, United States.
How many employees does Palisade Bio have?
Palisade Bio is in the 1-10 employee band.
How does Palisade Bio's funding compare to other Biotechnology startups?
Palisade Bio's latest round of $2.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Palisade Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Palisade Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.